Cytori Therapeutics Revenue and Competitors

Location

$87.2M

Total Funding

Estimated Revenue & Valuation

  • Cytori Therapeutics's estimated annual revenue is currently $3.5M per year.(i)
  • Cytori Therapeutics's estimated revenue per employee is $81,395
  • Cytori Therapeutics's total funding is $87.2M.

Employee Data

  • Cytori Therapeutics has 43 Employees.(i)
  • Cytori Therapeutics grew their employee count by 0% last year.

Cytori Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Customer Service Associate, MarketingReveal Email/Phone
4
Executive Assistant to the President and CEO & VP Finance & CFOReveal Email/Phone
5
ChairmanReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Cytori Therapeutics?

Cytori Therapeutics is discovering and developing proprietary, cell-based therapeutics utilizing adult stem cells derived from adipose, also known as fat tissue. The Company\'s investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem cells, Cytori is developing its proprietary Celution™ system to isolate and concentrate a patient\'s own stem cells in approximately a one-hour period of time. This system will dramatically improve the speed in which personalized, cell-based therapies can be delivered to patients.

keywords:N/A

$87.2M

Total Funding

43

Number of Employees

$3.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cytori Therapeutics News

2022-04-17 - Global Stromal Vascular Fraction Market 2022 Regional ...

Cytori Therapeutics; GE Healthcare; Ingeneron; Medikan International; Tissue Genesis; Genesis Biosystems; Human Med; IntelliCell BioSciences...

2022-04-17 - Regenerative Medicines Market to Witness Huge Growth in ...

... Companies | NuVasive, Stem Cells, Inc., Cytori Therapeutics, Inc ... However, gene therapies are expected to be the fastest emerging...

2022-04-17 - Umbilical Cord Blood (UCB) Stem Cell Market Size And ...

Cytori Therapeutics, Mesoblast, NeoStem, Opexa Therapeutics, Caladrius Biosciences, Osiris Therapeutics, Pluristem Therapeutics,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.4M435%N/A
#2
$5.2M430%N/A
#3
$5.4M4316%$206.8M
#4
$4.8M43N/AN/A
#5
$5M43-4%N/A